Stonehage Fleming (UK)’s Elevance Health ELV Stock Holding History

Stonehage Fleming (UK)’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$663K	Sell	4,755 -1,194	-20%	-$164K	0.3%	96
2015 Q3	$833K	Hold	5,949	–	–	0.4%	82
2015 Q2	$976K	Sell	5,949 -441	-7%	-$70.5K	0.44%	79
2015 Q1	$987K	Buy	6,390 +1,265	+25%	+$180K	0.46%	73
2014 Q4	$644K	Hold	5,125	–	–	0.32%	90
2014 Q3	$613K	Hold	5,125	–	–	0.27%	106
2014 Q2	$551K	Buy	5,125 +805	+19%	+$82.9K	0.22%	99
2014 Q1	$431K	Hold	4,320	–	–	0.18%	109
2013 Q4	$399K	Buy	+4,320	New	+$384K	0.16%	111

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Stonehage Fleming (UK)'s ELV Position: Q4 2015 in Review

Stonehage Fleming (UK) reduced its Elevance Health (ELV) stake by 20% in Q4 2015, selling an estimated $164K and leaving 4,755 shares worth $663K. The position accounts for 0.3% of the portfolio, ranked #96.

Stonehage Fleming (UK) first reported a position in ELV in Q4 2013 and has held it in 9 quarters since. The position peaked at $987K in Q1 2015. 765 funds tracked by Wall St. Rank hold ELV as of Q4 2015.

Stonehage Fleming (UK) held 4,755 shares of Elevance Health worth $663K as of Q4 2015.
Stonehage Fleming (UK) sold 1,194 Elevance Health shares in Q4 2015, an estimated $164K.
Elevance Health made up 0.3% of Stonehage Fleming (UK)'s portfolio in Q4 2015, its #96 holding.
Stonehage Fleming (UK) first reported a position in Elevance Health in Q4 2013 and has held it in 9 quarters since.
Stonehage Fleming (UK)'s Elevance Health position peaked at $987K in Q1 2015.
765 funds tracked by Wall St. Rank held Elevance Health as of Q4 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q4 2015, filed 11 Oct 2019.